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Abstract
Background: Malaria has a negative effect on the outcome of pregnancy. Pregnant women are at high risk of
severe malaria and severe haemolytic anaemia, which contribute 60-70% of foetal and perinatal losses. Peripheral
blood smear microscopy under-estimates sequestered placental infections, therefore malaria rapid diagnostic tests
(RDTs) detecting histidine rich protein-2 antigen (HRP-2) in peripheral blood are a potential alternative.
Methods: HRP-2 RDTs accuracy in detecting malaria in pregnancy (MIP >28 weeks gestation) and placental
Plasmodium falciparum malaria (after childbirth) were conducted using Giemsa microscopy and placental
histopathology respectively as the reference standard. The study was conducted in Mbale Hospital, using the
midwives to perform and interpret the RDT results. Discordant results samples were spot checked using PCR
techniques.
Results: Among 433 febrile women tested, RDTs had a sensitivity of 96.8% (95% CI 92-98.8), specificity of 73.5%
(95% CI 67.8-78.6), a positive predictive value (PPV) of 68.0% (95% CI 61.4-73.9), and negative predictive value (NPV)
of 97.5% (95% CI 94.0-99.0) in detecting peripheral P. falciparum malaria during pregnancy. At delivery, in non-
symptomatic women, RDTs had a 80.9% sensitivity (95% CI 57.4-93.7) and a 87.5% specificity (95%CI 80.9-92.1), PPV
of 47.2% (95% CI 30.7-64.2) and NPV of 97.1% (95% CI 92.2-99.1) in detecting placental P. falciparum infections
among 173 samples. At delivery, 41% of peripheral infections were detected by microscopy without concurrent
placental infection. The combination of RDTs and microscopy improved the sensitivity to 90.5% and the specificity
to 98.4% for detecting placental malaria infection (McNemar’s X
2> 3.84). RDTs were not superior to microscopy in
detecting placental infection (McNemar’s X
2< 3.84). Presence of malaria in pregnancy and active placental malaria
infection were 38% and 12% respectively. Placental infections were associated with poor pregnancy outcome [pre-
term, still birth and low birth weight] (aOR = 37.9) and late pregnancy malaria infection (aOR = 20.9). Mosquito net
use (aOR 2.1) and increasing parity (aOR 2.7) were associated with lower risk for malaria in pregnancy.
Conclusion: Use of HRP-2 RDTs to detect malaria in pregnancy in symptomatic women was accurate when
performed by midwives. A combination of RDTs and microscopy provided the best means of detecting placental
malaria. RDTs were not superior to microscopy in detecting placental infection. With a high sensitivity and
specificity, RDTs could be a useful tool for assessing malaria in pregnancy, with further (cost-) effectiveness studies.
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Plasmodium falciparum malaria remains a major contri-
butor of the disease burden in sub-Saharan Africa
(SSA). Children under five years of age and pregnant
women represent the most vulnerable population. Dur-
ing pregnancy, malaria infection leads to parasite
sequestration in the maternal placental vascular space,
with the consequence of increased risks of abortion,
stillbirth, prematurity, intra-uterine growth retardation
(IUGR) and maternal anaemia [1]. Malaria in pregnancy
(MIP) is associated with increased risk of low birth
weight (LBW) and prenatal, neonatal and infant mortal-
ity [2-5]. Infection with P. falciparum towards the end
of gestation increases the likelihood of placental infec-
tion [6]. A previous review by Desai et al estimated that
approximately one in every four pregnant women in
malaria endemic areas has evidence of placental infec-
tion at the time of delivery [7].
The diagnostic challenge is that conventional peripheral
blood microscopy is unable to detect all infections as para-
sites can be sequestered in the placenta [8-10]. Such sub-
microscopic infections increase the risk of anaemia and
poor foetal outcomes in seemingly aparasitaemic pregnant
women [9,11] thus increasing the risk of maternal and
perinatal mortality. Consequently, some clinicians are
reluctant to withhold anti-malarials for febrile pregnant
women, arguing that microscopy misses placental
infections.
However, malaria rapid diagnostic tests (RDTs) may
p r o v i d eas o l u t i o na se m e r g i n ge v i d e n c es u g g e s t st h a t
RDTs are capable of detecting placental malaria better
than microscopy and may detect sub-microscopic infec-
tions [12,13]. RDTs are lateral flow immuno-chromato-
graphic dipstick assays that detect either histidine rich
protein-2 (HRP-2) or Plasmodium lactate dehydrogenase
(pLDH) produced by infected red blood cells. Although
the large majority of RDTs comprise mAbs raised against
HRP2 or pLDH, it should be noted here that there are an
increasing number of tests that also include a Pan anti-
aldolase test line. Whereas good quality microscopy is
lacking in many resource-limited settings, as it requires
well-trained, competent personnel, infrastructure as well
as effective quality control and quality assurance [13],
RDTs are becoming increasingly available and affordable
[14].
With many countries in SSA following World Health
Organization (WHO) policy [15] and scaling up para-
site-based diagnosis for malaria through the use of
microscopy and RDTs, establishing the effectiveness of
RDTs in comparison to microscopy in detecting malaria
during pregnancy has become a priority.
Although there is limited evidence on the use of RDTs
among pregnant women [16,17], RDTs have been found
to be comparable in sensitivity to microscopy for
malaria [18] and to improve malaria diagnosis and qual-
ity of care at lower level health facilities [19-21]. The
few studies that have been done have based the accuracy
of RDTs on either placental smear or placental blood
polymerase chain reaction (PCR) and not histological
examination of the placenta at delivery [10,11,22-24].
This study compares HRP-2 RDTs to microscopy for
detecting peripheral malaria in feverish pregnant women
at time of recruitment in a hospital setting. In addition,
at delivery both RDTs and microscopy are compared to
placental histopathology performed to detect placental
malaria.
Methods
Study design and site
Study site
Mbale is a mountainous region with moderately low tem-
peratures and humidity, approximately 300 km north east
of Kampala, Uganda. It is a hyper-endemic region for
malaria with an estimated parasite prevalence rate of 56%
among children under five years [25]. The hospital con-
ducts over 300 deliveries with less than 30% having
attended antenatal care (ANC) in the same hospital. Insec-
ticide-treated net (ITN) ownership in the region is 52%
and net use by pregnant women is 42% [25]. Use of ANC
services has been reported to be as high as 90%, and cov-
erage with the second dose of intermittent preventive
treatment (IPT) of malaria in pregnancy (IPTp-2) with sul-
phadoxine-pyrimethamine (SP) is below 50% [26]. The
operational research was to determine the effectiveness of
RDTs when used in a hospital setting. Cross-sectional eva-
luation at time of recruitment compared accuracy of
RDTs to microscopy as a reference standard in detecting
peripheral parasitaemia during pregnancy. At delivery, a
second cross-sectional evaluation compared accuracy of
RDTs and microscopy to the reference standard of placen-
tal histology performed to detect placental malaria.
Study participants
Patients with fevers (temperature >37.2) or history of fever
in the last 24 hours, at a gestational age >28 weeks by
dates, were screened and consented to participate in the
study while at the antenatal clinic. Enrolled women were
clinically examined and information was collected on
social demographics and health-seeking behaviour using a
pre-tested questionnaire. A code was placed on the ANC
card of the participating mothers to enable easy identifica-
tion and follow-up at time of labour. Pregnant women
were encouraged to come and deliver in the hospital. All
study participants were given transport refund as well as a
free delivery set (maama kit) to ensure safe delivery. A fin-
ger prick was performed to test for malaria using both
RDTs and microscopy smears. In addition, a sample of
blood was collected on filter paper. Haemoglobin (Hb)
testing was done using a portable spectrophotometer
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field stain smear, was performed to guide. Women with
malaria, according to routine microscopy, were treated
with either quinine or artemisinin combination therapy
(ACT) according to the national treatment guideline.
During labour, participating mothers were identified
based on a code placed on their ANC cards. A finger
prick was performed to test for malaria using both
RDTs and microscopy and to estimate Hb. A sample of
blood was again collected on filter paper for PCR. After
delivery, the outcomes and weight of the child were
documented. A placental biopsy for histopathology was
also performed. Mothers were requested to bring chil-
dren back to the hospital for immunization and review
after six weeks.
Laboratory procedures
Rapid diagnostic testing for malaria
The commercially available RDT kit, “diagnosticks”
Malaria P. falciparum cassette (SSA Diagnostics and Bio-
tech Systems, Goa, India) was used. The lot number was:
S21004, manufactured in September 2009 and expiry
date of August 2011. Each box of 25 individually sealed
strips with a desiccant was supplied with loops, alcohol
swabs and lancets. Temperature and humidity conditions
were monitored during transportation and storage. After
performing a finger prick, two midwives independently
read each of the RDTs, 15 minutes after adding five
drops of the wash buffer according to the manufacturer’s
instructions. A result was interpreted as positive when
both the test line and control line showed pink and the
test line was also graded as either a strong or faint band.
The result was recorded as negative when only the con-
trol line showed pink or invalid when the control line did
not show up at all. Only one test was performed for each
patient. No repeat test was done for invalid tests and
used RDTs were discarded the same day. First reading
was considered for analysis in the case of discordant
result between readers.
Microscopy
Smears for the study were stained with 10% Giemsa for
30 minutes and examined under X100 objective lens of
the microscope by two independent laboratory technolo-
gists blinded to each other’s results. Microscopy examina-
tion of smears was done under oil immersion. The
number of asexual parasites was counted against 200 leu-
cocytes assuming an average leucocytes count of 8,000/µL.
Before a smear was declared negative, 200 high power
fields were examined.
Histopathology assessment of placental tissue
For every delivery conducted, placental biopsy was col-
lected within 30 minutes to determine malaria infection.
The specimen of the placental tissue (1.5 cm
3)w a s
excised away from the centre of the edge of the placenta
through the full thickness of the placenta including the
membranes [27]. Placental tissues were fixed in 10%
neutral buffered formalin and transferred to the pathol-
ogy laboratory at Makerere University, College of Health
Sciences. At the pathology laboratory, the fixed placental
biopsy specimens were grossed into 2-3 mm sections,
processed using standard procedures and embedded in
paraffin wax. They were sectioned using a microtometo
4µm [27]. The final tissue sections were stained with
haematoxylin and eosin for detection of active malaria.
Placental malaria infection was classified using the fol-
lowing definitions: 1) no infection (no evidence of para-
sites or pigment), 2) active acute infection (parasites in
the maternal erythrocytes in the intervillous space but
no/minimal pigment in fibrin/cells within fibrin), 3)
active chronic infection (parasites in maternal erythro-
cytes in intervillous space, pigment in erythrocytes and
circulating monocytes within intervillous space and pig-
ment in fibrin or cells within fibrin and/or chronic vil-
lous syncytiotrophoblast/stroma and, 4) past infection
(parasites not present, pigment confined to fibrin or
cells within fibrin [28]. The enrolled sample of 434 preg-
nant febrile women at ANC was sufficient to detect a
minimum sensitivity of 90% and specificity of 75% at a
precision of 0.05 and power of 80%. The prevalence of
malaria was estimated at 40% [28].
Molecular assessments
A convenient sample of 50% of all discordant results
(RDTs and microscopy) was selected for molecular assess-
ment due to limited resources. Using the filter papers sam-
ples collected, PCR was performed to identify presence of
infection in samples positive by microscopy, that had
negative RDTs and samples negative by microscopy but
positive by RDTs. Parasite DNA was isolated from filter
paper using the chelex extraction method [29]. To detect
P. falciparum , the block-3 region of merozoite surface
protein-2 (MSP-2) was amplified by nested PCR with pri-
mers corresponding to conserved sequences flanking this
region [30], followed by primers to amplify the IC3D7 and
FC27 allelic family, using conditions described previously
[31]. PCR products were analysed by electrophoresis using
2% agarose gel.
Quality control measures
All study research assistants (midwives) were centrally
trained and had continuous support supervision by the
laboratory technician and site supervisor. The study
RDTs were centrally purchased and delivered to the hos-
pital by the study coordinator, with a reserve kept at the
Malaria Consortium offices. Manufacturer’ss t o r a g et e m -
perature specifications (4-30°C) were monitored and
maintained both at storage and during transportation.
The slides and RDTs were read by two persons blinded
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ble for aggregating the data onto the case record forms.
The practice of recording this information was checked
during monthly support supervision visits. Placental his-
tology smears were first examined by a senior pathologist
and later, blindly, quality controlled by a second reader at
M b a r a r aU n i v e r s i t yp a t h o l o g yd e p a r t m e n t .N ot i e -
breaker reading was performed.
Statistical methods
Clinical and social demographic data were collected at the
time of enrolment and linked through unique identifier
numbers. At delivery, outcomes of smear and placental
histology results were also recorded in addition to repeat
RDTs and peripheral microscopy. Data were entered using
EpiData ("The EpiData Association” Odense, Denmark)
and analysed with SPSS 12 (SPSS USA 2005). For malaria
in pregnancy, results were categorized as positive and
negative for both RDTs and microscopy. Sensitivity, speci-
ficity PPV and NPV were calculated by comparing the
proportion of positive and negative results for each RDT
with expert field microscopy (these are not certified WHO
experts). Categorical variables were compared using chi
2test. Weighted positive likelihood ratio (LR) was calcu-
lated by dividing probability that a positive test result is a
true positive by probability that a positive test result is a
false positive as LR = (prevalence)(sensitivity)/(1-preva-
lence)(1-specificity) and the negative LR = (prevalence)(1-
sensitivity)/(1-prevalence)(specificity). Logistic regression
analysis was conducted to determine factors that predicted
malaria test results and level of associations presented as
odds ratios.
Placental results were categorized as positive (acute and
chronic infections) or negative (past and not infected) for
histopathology. Associations between placental infection
and independent variables were assessed using odds ratios
with 95% confidence intervals calculated and interpreted
as significant if two-sided p -value was less than 0.05. For
placental malaria, the sensitivity, specificity, PPV and NPV
were calculated for both RDTs and microscopy in compar-
ison to the reference standard placental histology. The
McNemar test (X
2) was used to examine whether the two
proportions derived from the marginal sums of the
matched sample contingency table significantly differed.
McNemar’s test result was computed: X
2 = ∑ (O-E)
2/E
where O is observed, E is expected value at 5% significant
level [32]. Odds ratios and 95% confidence intervals of the
discordant cells were computed to show the level of this
association.
Ethical considerations
The study was conducted according to the principles of
the declaration of Helsinki and the international guide-
lines of biomedical research involving human subjects.
The study protocol was approved by Mbale Hospital
Research and Ethical Committee and Uganda National
Council of Science and Technology. All participants
provided written informed consent to participate in the
study.
Results
Patient profile
Between February and July 2010, 534 febrile women
attending ANC clinic were screened for eligibility to parti-
cipate in the study, out of which 434 were enrolled. The
screen failures were due to low gestational age (< 28
weeks of amenorrhoea). After testing with RDTs at time
of enrolment, four women had invalid results and were
excluded from analysis while one had no microscopy
results. At delivery, 208/434 (48%) returned to the hospi-
tal. From the delivery data, 173/208 (83%) was analysed
after excluding 28 without placental biopsies histology
results and seven women who lacked unique linking data
for both microscopy and RDTs results (Figure 1).
Malaria in pregnancy (gestational malaria)
One third of the febrile women were primigravidae with
a mean age of 19 years. Of these, 406/434 (94%) had
attended ANC two or more times with just 58/434
(13%) having received a second dose of sulphadoxine-
pyrimethamine for IPTp at time of enrolment. Among
421 respondents, 343 (82%) reported having slept under
a mosquito net the night before. Prevalence of clinical
malaria in pregnancy was 164/433 (38%) based on per-
ipheral blood Giemsa smears microscopy, while RDTs
were positive among 225/430 (52%)(Table 1). RDTs had
a sensitivity of 96.8% (95% CI 92.0-98.8), specificity of
73.5% (95% CI 67.8-78.6), Positive Predictive Value
(PPV) of 68.0% (95% CI 61.4-73.9), and Negative Predic-
tive Value (NPV) of 97.5% (95% CI 94.0-99.0). The
weighted likelihood ratios (LR) of positive test (LR+)
and negative tests (LR-) were calculated. The LR+ was
2.1 (95% CI 1.7-2.6) which means that a pregnant
woman with malaria is about two times more likely to
have a positive RDT test than a woman who has not got
malaria in pregnancy. A LR- of 0.025 (95% CI 0.01-0.06)
means that the probability of having a negative test for
pregnant women with malaria is 0.025 times that of
those without malaria. Women without malaria are
about 40 times more likely to have negative test than
women with malaria. Given the LR, RDTs were better at
‘ruling out malaria infection’ than in confirming active
malaria infection (Table 2). PCR was selectively con-
ducted as a spot check to evaluate discordant results on
a total of 45 ‘false RDTs’ samples. PCR was positive for
1/37 RDT false negative and negative for 2/8 RDT false
positive samples. These spot check PCR results did not
affect the computed accuracy of the RDTs.
Kyabayinze et al. Malaria Journal 2011, 10:306
http://www.malariajournal.com/content/10/1/306
Page 4 of 11Factors associated with malaria in pregnancy
Primigravidae were more than twice as likely to have clini-
cal malaria when compared with multigravidae women
(aOR 2.5, p < 0.001). Women with low Hb were more at
risk of having malaria than those with Hb greater than
11 g/dl (aOR 1.6, p = 0.024). Women who reported having
slept under a mosquito net the night before were two
times less likely to have malaria than those who did not
use a mosquito net (aOR 0.44 p = 0.001) (Table 3).
Placental malaria and its associated factors
At the end of gestation, 208/434 (48%) enrolled mothers
returned for hospital delivery. The delivery outcomes were
186/208 (89%) live births, 11 pre-term, eight still births
(five fresh still births), and three unrecorded outcomes. Six
(3%) were surgical deliveries. One maternal death occurred
due to post-partum haemorrhage and three neonatal
deaths on the first-day of life due to prematurity. Further
analysis was then restricted to 173 patients with complete
histopathology results.
Of the 178 placental tissue examined, 38/178 (21.3%
[95% CI 16.0-27.9]) had malaria infection, of which 21/173
(12.1% [95% CI 7.8-17.4]) were active infections (16 acute
and five chronic) and the rest past infections. RDTs had a
sensitivity of 80.9% (95% CI 57.4-93.7), specificity of 87.5%
(95% CI 80.9-92.1), PPV of 47.2% (95% CI 30.7-64.2) and
NPV of 97.1% (95% CI 92.2-99.1) against the reference
standard of placental histology in detecting placental
P. falciparum infections. Combination results of RDTs
and microscopy improved the total sensitivity to 90.5 (95%
CI 68.2-98.3) for detecting placental malaria infection and
NPV to 98.4 (95% CI 93.9-99.7) but lowered the specificity
and PPV (Table 4). The McNemar’st e s t( X
2)w a sp e r -
formed to test whether RDTs were better than microscopy
in detecting placental malaria. The X
2 values among the
placental-infected and non-infected mothers were 0.25
and 1.565 respectively, both less than the 3.84 cut-off for a
significant difference at 5% (Additional file 1). The
extended McNemar X
2 confirmed that combined tests of
RDTs and microscopy were significantly better than a sin-
gle test (X
2 of 6.125 for infected and 9.00 none infected
both >than 5.00 cut off). At delivery, the mean age was
25 (SD 6.0) years and 47/166 (28%) were teenagers. The
mean haemoglobin concentration was 11 (SD 3.0) g/dL.
Overall, 64/161(40%) of the mothers were anaemic at
delivery (Hb <11.g/dL). Using a logistic regression model,
the clinical factors associated with placental infection were
late pregnancy malaria infection (aOR = 20.9, p < 0.001)
and poor foetal outcome (aOR = 37.9, p = 0.007). There
was no statistically significant association between placen-
tal infection and ITN use, IPTp use and birth weight
(Table 5).
Discussion
This study found a malaria prevalence of 38% using micro-
scopy and 54% with RDTs among febrile pregnant women
at ANC. When compared with microscopy, RDTs demon-
strated acceptable sensitivity (97%) and specificity (74%) for
the diagnosis of P. falciparum malaria among febrile preg-
nant women attending ANC at a hyper-endemic region in
eastern Uganda. The procedures in this study were per-
f o r m e db yn u r s e sa n dm i d w i v e sa tt h eh o s p i t a lA N Cc l i n i c .
The operational nature of this evaluation allowed the inves-
tigators to demonstrate that RDTs are reliable for diagnosis
of P. falciparum malaria in pregnancy when performed by
midwives. These findings are comparable to previous
reports of diagnosed malaria in pregnancy ranging from
9% to 60% in sub-Saharan Africa [33].
The high sensitivity of RDTs among symptomatic preg-
nant mothers is comparable to results from a previous
534 screen 
434 febrile women enrolled 
164(38%) smear positive 
173 Placental histology results 
•  16 Active acute infections 
•  4 Chronic infections 
•  16 Past infection 
208(47%) Hospital deliveries 
•  186 Full term  
•  11 pre-term* 
•  8 still births 
35 Excluded from analysis 
•  13 Poor /missing smear/records 
3- Birth before admission         
8  missing tissue                        
9  poor tissue taken/preserved 
226 (53%) Delivery outside 
the hospital 
Post Natal child follow-up 
Figure 1 Study profile of participants in the study to detect
placental malaria infection using RDTs in Mbale Regional
Hospital, Uganda. The figure shows the study conduct when
women were screened, enrolled and followed up to delivery and
the samples included in the final analysis
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[34]. The high sensitivity gives confidence to clinicians
that RDTs are unlikely to miss malaria infections in preg-
nancy. The PPV was low and this could be due to false
positive results attributable to the persistent nature of
HRP-2 antigenemia already documented by previous stu-
dies [34-36]. The false positive may also have been due to
better detection of malaria by HRP2 test in respect to the
microscopy used as reference [37]. Using PCR to validate
the false positives did not alter this result [37]. This was
unexpected as the sensitivity of PCR has been documen-
ted as significantly higher than RDTs [17].
This study found a relatively low specificity but a high
negative predictive value of 97.5%, almost certainly
excluding malaria infection. This NPV result gives confi-
dence that if RDTs are used to diagnose malaria in preg-
nancy very few infected women will be missed. Moreover,
false negatives were linked to very low parasite densities
that are unlikely to be the cause of illness in such an ende-
mic setting. The consequences of a false negative in an
endemic area, particularly when related to low parasitae-
mia, mean that the patient is unlikely to die. The infection
may either clear without illness, as people living in ende-
mic areas have partial immunity, or clinical symptoms will
recur and they would seek care again.
For clinical application, sensitivity and specificity of
the RDTs can be combined into a single measure called
likelihood ratio (LR). LR provides a summary of how
Table 2 Accuracy of peripheral blood RDTs in detecting malaria in pregnancy among 432 febrile women attending
antenatal care at Mbale regional referral hospital between March and November 2010
Accuracy Parameter¶ Peripheral RDTs for symptomatic pregnant women(95% CI)
Sensitivity 96.8(92.3-98.8)
Specificity: 73.5(67.8-78.6)
Positive predictive value 68.0(61.4-73.9)
Negative predictive value 97.5(94.0-99.0)
Likelihood ratio
Positive LHR[W] 2.13(1.72-2.62)
Negative LHR [w] 0.03(0.01-0.06)
Test sensitivity = conditional probability that the test will be positive if the condition is present
Test specificity = conditional probability that the test will be negative if the condition is absent
W = weighted for prevalence
Table 1 Baseline characteristics of 434 febrile pregnant women enrolled in the malaria rapid diagnostic test in the
antenatal clinic, January- Sept 2010 at Mbale Hospital, Uganda
Demographic characteristic All women (N = 434) Primiparae 131(30%) Para II & III 153(36%) Multiparae 150 (34%)
Educational ≤7 y(%,n) 52 (216/434) 41(51/123) 50 (71/151) 70(96/147)
Age yrs, (median, IQR range) 24(20-28) 19(15-37) 23(16-39) 30(17-42)
Teenager (%,n) 22 (146/434) 75(98/131) 26(40/153) 3(4/150)
WOA(mean, range) 32(28-36) 33(28-41) 32(35-40) 32(23-40)
Married %(n) 91(387/434) 77(101/131) 93(142/149) 96(144/150)
HIV Positive %(n) 5.5(24/434) 5.7(7/122) 5.3(8/151) 6.2(9/144)
Unknown HIV status%(n) 8.5(36/434) 9.0(11/122) 6.5(10/153) 10.4(15/144)
Anaemia % (n) Hb <11 gldl 43(185/150) 57 (74/131) 45(69/153) 39(59/150)
Hb <8 g/dl %(n) 4(17/434) 4.6 (5/131)) 2(3/153) 5.3(8/150)
Back pain%(n) 19(82/434) 21(28/131) 22(33/153) 14(21/150)
Abdominal pain %(n) 24(103/434) 22(29/131) 21(32/153) 28(42/150)
Headache % (n) 19 (82/434) 38(50/131) 28(43/153) 36(54/150)
Temperature (°C, mean ±SD) 37.0 ± 0.9 37.2 ± 0.9 36.9 ± 0.8 36.9 ± 0.8
ANC visits ≥2 visits %(n) 94 (406/434) 94(124/130) 72(94/131) 93(137/147)
IPTp-1%(n) 62 (269) 69(75/108) 72(94/131) 78(100/127)
IPTp-2%(n) 13.4(58/434) 13(17/131) 15(23/153) 17(26/150)
Slept under net %(n) 82(343/434) 74(96/129) 83(123/148) 88(126/144)
DIAGNOSTIC TOOLS
Routines smear positive(%,n) 49(205/434) 64(80/125) 53(77/147) 37.2(57/148)
HRP-2 positive(%,n) 52(225/430) 66.4(87/131) 53(81/152) 39.3(59/150)
Microscopy positive (%,n) 38(164/433) 51(67/131) 41(63/152) 23(34/150)
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are to have a positive (or negative) result than women
without malaria. This study found a LR+ of two which
means that a pregnant woman with malaria is about two
times more likely to have a positive RDT test than a
woman who has not got malaria in pregnancy. It also
found a LR- of 0.025 which means that the probability
of having a negative test for pregnant women with
malaria is 0.025 times of thato ft h o s ew i t h o u tm a l a r i a .
Therefore, women without malaria are about 40 times
more likely to have negative test than women with
malaria. These results imply that RDTs were better at
‘ruling out malaria infection’ than in confirming active
malaria infection. The benefit of likelihood ratios is that
they can be used to help the clinician adapt the sensitiv-
ity and specificity to tests of individual patients [38,39].
In summary, the high sensitivity, specificity, NPV and
the LR of RDTs in symptomatic pregnant women,
demonstrated in this study, gives confidence to the mid-
wife (or physician) to treat all RDT-positive and not
treat women with a negative RDT. However, to make
sure that all pregnant women receive the doses of SP
for IPT that will hopefully clear any infection and pla-
cental infection if present, the midwife should investi-
gate for non-malarial causes of fever when the RDT is
negative.
This study found that there was an association
between RDT result and clinical or demographic factors.
Table 3 Frequency and risk factors of Plasmodium falciparum in 432 febrile pregnant women attending antennal clinic
Mbale Hospital between February and October 2010
Parameter Measure(n) Malaria infection* cOR aOR P Value
Parity Primigravidae(n = 212) 105 (50%) 2.72 (1.82-4.07) 2.48 (1.64-3.75) 0.001‡
≥2 pregnancies(n = 220) 59(27%) 1.0 1.0
Age <20 years (n = 141) 70(50%) 2.06(1.37-3.12) 1.09(0.63-1.92) 0.739
≥20 years (291) 94(32%) 1.0 1.0
Maternal Anaemia <11.0 g/dL (n = 202) 91(45%) 1.76(1.19-2.61) 1.61(1.06-2.43) 0.024‡
≥11.0 g/dL (n = 230) 73(32%) 1-0 1.0
HIV sero-status Positive or Unknown (n = 76) 34(44%) 1.41(0.85-2.32) 1.18(0.68-2.03) 0.563
Negative (n = 356) 130(37%) 1.0 1.0
Gestational age (WOA) 35 > weeks (n = 132) 59(45%) 1.50(0.98-2.27) 1.07(1.01-1.21) 0.018‡
< 35 weeks (n = 300) 105(35%) 1.0 1.0
Previous IPTp use Yes (n = 296) 108(37%) 0.82(0.54-1.24) 1.23(0.78-1.92) 0.368
No(n = 136) 56(41%)
Uses Net (ITN) Yes (n = 343) 115(34%) 0.41(0.26-0.66) 0.47(0.26-0.71) 0.001‡
No (n = 89) 49(55%) 1.0 1.0
Education None or less than 7 years(n = 228) 89(39%) 0.91(0.62-1.34) 1.25(0.82-1.90) 0.298
More than 7 years(n = 204) 75(37%) 1.0 1.0
*Peripheral smear positive
Table 4 Accuracy of microscopy and RDT in detecting placental malaria infection in peripheral blood among 173
women at Mbale regional referral hospital between March and November 2010
Placental histology
+(n = 21) (n = 152) Total Accuracy measure(95%CI)
Microscopy + 17 12 29 Sensitivity 76.2(52.4-90.8)
4 140 144 Specificity 92.1(86.3-95.7)
PPV* 57.1(37.4-74.9)
NPV‡ 96.6(91.7-98.7)
RDTs + 17 19 36 Sensitivity 80.9(57.4-93.7)
4 133 137 Specificity 87.5(80.9-92.1)
PPV 47.2(30.7-64.2)
NPV 97.1(92.2-99.1)
Microscopy + 19 27 46 Sensitivity 90.5(68.2-98.3)
+RDTs 2 125 127 Specificity 82.2(75.0-87.7)
PPV 41.3(27.3-56.7)
NPV 98.4(93.9-99.7)
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examines the patient to estimate the chance (probability)
of malaria prior to performing a test. A patient’s prob-
ability of having malaria after the test result is known
(post-test probability) is what the clinicians are most
interested in as it can help in deciding where to confirm
a diagnosis or rule it out. The actions taken after receiv-
ing the test results are weighed in light of the history
and examination obtained prior to testing. The factors
that influenced post-test probability in this study are
consistent with known risk factors associated with
malaria infection, and include parity, low maternal hae-
moglobin, sleeping under a mosquito net and advanced
gestational age. Previous studies have shown that primi-
gravidae are at increased risk for malaria in pregnancy
and most cases of malaria in pregnancy happen towards
the end of gestation [1,6,40,41]. The findings affirm the
notion that HRP2 RDTs are most useful when the clini-
cal and social demographic context is known because of
varying risk levels for malaria during pregnancy [42].
In this study, direct examination of the placental tissue
showed that 21% of women had placental infection of
which 12% were active infections on the day of delivery.
The study demonstrated a modest level of accuracy
(80.9% sensitivity, 87.5% specificity, 98% NPV) of RDTs
in detecting placental malaria using peripheral blood at
time of delivery. The study allowed the investigators to
characterize the burden of placental infection among
pregnant women with history of febrile illness during the
third trimester. The prevalence of placental malaria is
similar to that reported from Nigeria [43]. However
active placental malaria infection at the time of delivery
in this study was lower than the reports from Cameroon
at 60% [9] and 34% in a study in Ghana [11]. The possible
reason for the difference with previous studies is that
those studies used placental microscopy smears rather
than histology to detect placental infection. In addition, it
is possible that this study presents lower rates of placen-
tal malaria because of the high use of IPT-1 at 70% and
ITN use at 84%. Use of IPT and ITNs reduces the risk of
malaria and placental malaria [44]. The current study
highlighted that as parity and use of ITNs increase, there
is a significant reduction in the risk of placental malaria
infection. There was no significant difference between
RDTs and microscopy in detecting placental malaria. The
combined sensitivity and specificity of both peripheral
microscopy and RDTs detecting placental malaria was
higher than using individual tests and this difference was
statistically significant [32]. This finding is similar to that
reported in a study in Cameroon where a combination of
microscopy and RDTs detected more placental infection
[10]. This implies that RDTs could complement periph-
eral microscopy in excluding placental malaria. The clini-
cal relevance of this is that women with negative tests for
both microscopy and RDTs should not be treated with
anti-malarial drugs as chances of having placental malaria
are minimal. However, intermittent presumptive treat-
ment needs to be advocated for and promoted to mini-
mize the risks of placental infection and the associated
complications to the mother and foetus [3,11,45]. Malaria
in pregnancy and acute placental infection increase the
risk of clinical malaria in the mother, severe anaemia,
Table 5 Frequency and risk factors of placental Plasmodium falciparum infection among 166 delivering mothers in
Mbale Hospital between February and October 2010
Parameter Categories(n) Placental Infection cOR aOR P Value
Parity Primigravidae(n = 83) 14 (17%) 2.60 (0.95-7.15) 1.01 (0.21-4.72) 0.994
≥2 pregnancies(n = 83) 6(7%) 1.0 1.0
Age < 20 years (n = 47) 9(19%) 2.33 (0.90-6.05) 1.68 (0.44-6.46) 0.451
≥20 years (119) 11(9%) 1.0 1.0
Maternal Anaemia <11.0 g/dL (64) 11(17%) 2.31 (0.87-6.10) 2.09 (0.63-6.96) 0.222
≥11.0 g/dL (n = 97) 8(8%) 1.0 1.0
Pregnancy outcome Still birth (n = 14) 6(36%) 1.34(0.16-11.12) 37.9 (2.70-528.80) 0.007‡
Live full term(n = 149) 14(9%)
Birth weight < 2500 gm (n = 11) 1(9%) 1.34 (0.16-11.12) 17.04 (0.63-460.7) 0.092
≥2500 gm(n = 97) 8(8%)
Previous IPTp use Yes (n = 118) 17(14%) 0.40 (0.11-1.42) 0.31 (0.07-1.40) 0.127
No(n = 30) 7(23%) 1
Uses Net (ITN) Yes (n = 136) 13(10%) 0.34 (0.13-0.96) 1.02 (0.22- 4.58) 0.977
No (n = 30) 7(23%) 1.0 1.0
MIP* Smear Positive(n = 61) 16(26%) 8.98 (2.84-28.37) 20.95 (3.99-110.05) 0.001‡
Smear Negative(n = 105) 4(4%) 1.0 1.0
*Malaria in pregnancy
aOR = Adjusted odds ratios
‡ Statistically significant
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Page 8 of 11intra uterine growth retardation and death in infancy [1].
In RDT negative pregnant women, IPT with SP should
be given. Although some studies have reported good effi-
cacy of SP, its future usefulness is questionable [46] given
the current prevalence of mutant parasites [47,48], and
yet alternative effective and safe replacement remains
unclear. The sensitivity of the RDT in this study was
acceptably high and any clinician who does not treat the
patient with a positive RDT would be negligent, but
should also explore other reasons for fever, which could
in any case coexist with malaria. Some mothers had false
positive RDTs without placental or peripheral infection
detected. The consequence of false positive result is that
someone may be treated for malaria when they are not
infected. Based on these study results, health workers will
over-treat fewer mothers than if they treated all sympto-
m a t i cw o m e n .I ti sa l s ol i k e l yt h a ts o m eo ft h e s em a l a r i a
infections were identified early before migration of infec-
tion to the placenta as shown by positive peripheral
smear readings [43].
This study was integrated into the existing health sys-
tem and done by the human resources who would be
available for eventual scale-up and in close collaboration
with National Malaria Control Programme. The study
built on previous work published by others by using an
implementation/prospective approach and providing an
appropriate context in which malaria is diagnosed. This
approach in study conduct was important to validate
effectiveness of RDTs given this can be context specific
[42]. It has been argued that the effectiveness of RDTs
is dependent on malaria transmission intensity and the
operational context.
The main limitations of this study included the low
hospital delivery rate of 47%, which made it impossible
to analyse the deliveries out of the hospital. However
the hospital delivery rate was higher than the national
rate of 30% and the authors attribute this to the study
mothers being incentivized to deliver in the hospital.
Some samples were not analysed due to missing data,
an expected challenge when using data from a routine
ANC care setting. These limitations are to be expected
in most operational studies but this approach allows the
team to learn through implementation. Another limita-
tion is that the RDTs (Diagnosticks) selected for the
study displayed a very low sensitivity (59%) against low
parasitaemia blood samples in an independent evalua-
tion conducted by FIND/WHO [49]. Additionally, it has
been noted that this RDT also has quite a high false
positivity rate of 8% (8 out of 100 negative blood sam-
ples tested positive for P. falciparum ). The inherently
higher rate of false positives recorded for this test may
explain the poor PPV observed in the study and also
account for lower specificity percentages. It is recom-
mended by the WHO that an RDT should have at least
95% sensitivity at 100 p/µl [50]. It is possible that
another HRP-2 RDT would perform better in terms of
sensitivity in this context. In order to provide a more
comprehensive and thorough assessment of performance
of an RDT when compared to microscopy or any other
experimental method, future studies should make use of
t h eW H Oi n t e r a c t i v eo n l i n eg u i d ef o rs e l e c t i o no f
RDTs. Studies should include well characterized RDTs
with much higher sensitivities and specificities and more
than one test evaluated to provide a more robust assess-
ment of their performance in this context.
Conclusions
Prevalence of active placental malaria infection was 12%
in a malaria endemic setting in Uganda. RDTs were
accurate and comparable to microscopy for diagnosing
malaria in pregnancy when performed by midwives dur-
ing ANC. RDTs were not statistically better than micro-
scopy in detecting placental infection and both methods
were less than optimal. Combined use of RDTs and
microscopy on peripheral blood improved detection of
placental malaria infection. RDTs high sensitivity and
specificity of RDTs means they can complement micro-
scopy for diagnosing P. falciparum malaria in pregnancy
with further (cost-) effectiveness studies.
Additional material
Additional file 1: Matched samples table for infected (n = 21) and
non malaria infected placental (n = 152) readings comparing RDTs
to microscopy reading based on histopathology as a reference
standard among delivering mothers in Mbale Hospital between
February and October 2010. The table show the contingency table
marginal totals used to compute the McNemar X
2 test comparing RDTs
to microscopy reading based on histopathology as a reference standard
among 173 delivering mothers in Mbale Hospital between February and
October 2010. The X
2 values among the placental-infected and non-
infected mothers were 0.25 and 1.565 respectively, both less than the
3.84 cut-off for a significant difference at 5%. The comparison in c and d
compares the combined results of both RDTs and microscopy to that of
RDTs alone (two degrees of freedom). The extended McNemar X
2
confirmed that combined tests of RDTs and microscopy were
significantly better than a single test (X
2 of 6.125 for infected and 9.00
none infected both >than 5.00 cut off).
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